Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW January 2002

Volume 11
Issue Number 1
January 2002
ISSN 10593802

Fludarabine/Cyclophosphamide/Rituximab in CLL

Combining fludarabine, cyclophosphamide and rituximab (R) as a front-line therapy for chronic lymphocytic leukemia (CLL) results in a significantly higher response rate than individual agents or fludarabine (F) and cyclophosphamide (C) together.
Go to Previous Page
Go to Next Page

Source & Additional Reading

43rd Annual Meeting of American Society of Hematology.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW January 2002

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW January 2002